Results 191 to 200 of about 497,848 (343)
ABSTRACT The off‐label use of glucagon‐like peptide‐1 receptor agonists (GLP‐1ra) among people without obesity and/or diabetes is rapidly expanding, despite a lack of clinical justification or safety data in this population. This Perspective explores the sociomedical dimensions of this trend, highlighting key research gaps and emerging hypotheses ...
Fernanda Baeza Scagliusi +5 more
wiley +1 more source
Unaware and unrestrained: binge-eating behavior in epileptic absence seizures. [PDF]
Marini I +5 more
europepmc +1 more source
ABSTRACT Objective This study aimed to describe parental communication with children around obesity management medications (OMMs) and child, parent, and family factors associated with communication. Methods Parents (N = 211; 80% mothers; 89% White) prescribed OMMs at a medical center participated in a survey about communication with children about OMM ...
Keeley J. Pratt +3 more
wiley +1 more source
Binge Eating Disorder in Bipolar I Disorder: Prevalence, Childhood Trauma, and Clinical Correlates. [PDF]
Karabıyık B +2 more
europepmc +1 more source
A Comprehensive Review of the Genetic Etiology and Management of Orofacial Clefts
ABSTRACT Cleft lip (CL) and cleft palate (CP), collectively referred to as orofacial clefts (OFCs), are among the most common birth defects and can have significant effects on speech, nutrition, and physical and psychosocial development. Manifestation, classification, and treatment plans of OFCs are diverse and not standardized.
Emily Kim +3 more
wiley +1 more source
Beyond diagnosis: a network approach to the emotional and control processes involved in the binge eating spectrum disorders. [PDF]
Reivan Ortiz GG +5 more
europepmc +1 more source
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens +7 more
wiley +1 more source
Patient experiences with liraglutide for obesity and binge eating disorder-A qualitative study. [PDF]
Følling IS +3 more
europepmc +1 more source
Abstract Background and aims Lower risk guidelines for safer levels of cannabis use could help to reduce the health burden posed by cannabis use disorder (CUD). We aimed to estimate risk thresholds for CUD based on delta‐9‐tetrahydrocannabinol (THC) consumption using standard THC units (1 unit = 5 mg THC).
Rachel Lees Thorne +9 more
wiley +1 more source
Rethinking BMI in Depression: Could It Be Binge Eating or Atypical Depression? [PDF]
Wingate K, Ruelke E, Darwish R.
europepmc +1 more source

